Josef R. Bencsik

发表

Discovery and preclinical pharmacology of a selective ATP-competitive Akt inhibitor (GDC-0068) for the treatment of human tumors.

Jun Liang, J. Blake, B. Brandhuber, 2012, Journal of medicinal chemistry.

Discovery of dihydrothieno- and dihydrofuropyrimidines as potent pan Akt inhibitors.

Tyler T. Risom, J. Blake, B. Brandhuber, 2010, Bioorganic & medicinal chemistry letters.

Diversification of the three-component coupling of 2-aminoheterocycles, aldehydes, and isonitriles: efficient parallel synthesis of a diverse and druglike library of imidazo- and tetrahydroimidazo[1,2-a] heterocycles.

T. Kercher, J. Josey, Josef R. Bencsik, 2007, Journal of combinatorial chemistry.

Discovery and SAR of spirochromane Akt inhibitors.

Tyler T. Risom, S. Gross, J. Blake, 2011, Bioorganic & medicinal chemistry letters.

Efficient, stereoselective synthesis of oxazolo[3,2-a]pyrazin-5-ones: novel bicyclic lactam scaffolds from the bicyclocondensation of 3-aza-1,5-ketoacids and amino alcohols.

T. Kercher, M. O'Sullivan, J. Josey, 2003, Organic letters.

C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase Activators.

P. Coward, Jaehyeon Park, M. Véniant, 2014, ACS medicinal chemistry letters.

Discovery of spirocyclic sulfonamides as potent Akt inhibitors with exquisite selectivity against PKA.

Tyler T. Risom, S. Gross, J. Blake, 2011, Bioorganic & medicinal chemistry letters.

Discovery of pyrrolopyrimidine inhibitors of Akt.

Tyler T. Risom, S. Gross, J. Blake, 2010, Bioorganic & medicinal chemistry letters.

Original paper: Identification of the honey bee swarming process by analysing the time course of hive vibrations

Andrei Lucian, Martin Bencsik, Mike Baxter, 2011 .

C5-Alkyl-2-methylurea-Substituted Pyridines as a New Class of Glucokinase Activators.

P. Coward, Jaehyeon Park, M. Véniant, 2014, ACS medicinal chemistry letters.